282 related articles for article (PubMed ID: 33173174)
1. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
[TBL] [Abstract][Full Text] [Related]
2. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
3. A study on diagnostic performance of different immunohematological diagnostic tests in assessing the prevalence of ABO Hemolytic Disease of Newborn in the antenatal O group mothers and their neonatal outcome in a tertiary care hospital in Northern India.
Deb J; Jain A; Kaur D; Bahadur A; Basu S; Negi G
Transfus Apher Sci; 2024 Feb; 63(1):103864. PubMed ID: 38135544
[TBL] [Abstract][Full Text] [Related]
4. Morbidity of ABO haemolytic disease in the newborn.
Bhat YR; Kumar CG
Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
[TBL] [Abstract][Full Text] [Related]
5. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate.
Bakkeheim E; Bergerud U; Schmidt-Melbye AC; Akkök CA; Liestøl K; Fugelseth D; Lindemann R
Acta Paediatr; 2009 Dec; 98(12):1896-901. PubMed ID: 19703120
[TBL] [Abstract][Full Text] [Related]
6. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
Chen JY; Ling UP
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
[TBL] [Abstract][Full Text] [Related]
7. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
Front Immunol; 2021; 12():698541. PubMed ID: 35003054
[TBL] [Abstract][Full Text] [Related]
8. Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis.
Li P; Pang LH; Liang HF; Chen HY; Fan XJ
Fetal Pediatr Pathol; 2015; 34(6):341-50. PubMed ID: 26359685
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for readmission for hyperbilirubinemia in neonates with ABO hemolytic disease: a single-center retrospective cohort study.
Xu C; Bao Y; He Y; Wu M; Zhu J
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2238106. PubMed ID: 37487760
[TBL] [Abstract][Full Text] [Related]
10. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?
Brouwers HA; Overbeeke MA; van Ertbruggen I; Schaasberg W; Alsbach GP; van der Heiden C; van Leeuwen EF; Stoop JW; Engelfriet CP
Lancet; 1988 Sep; 2(8612):641-4. PubMed ID: 2901516
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
[TBL] [Abstract][Full Text] [Related]
12. IgG subclasses of anti-A and anti-B antibodies bound to the cord red cells in ABO incompatible pregnancies.
Ukita M; Takahashi A; Nunotani T; Kihana T; Watanabe S; Yamada N
Vox Sang; 1989; 56(3):181-6. PubMed ID: 2728395
[TBL] [Abstract][Full Text] [Related]
13. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.
Kaplan M; Na'amad M; Kenan A; Rudensky B; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
Pediatrics; 2009 Jan; 123(1):e132-7. PubMed ID: 19114458
[TBL] [Abstract][Full Text] [Related]
14. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
15. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
Akgül S; Korkmaz A; Yiğit S; Yurdakök M
Turk J Pediatr; 2013; 55(5):506-9. PubMed ID: 24382531
[TBL] [Abstract][Full Text] [Related]
16. [The Correlation Analysis between the Titer of IgG Anti-A/B Erythrocyte Antibody In Vivo of the Neonate and the Severity of Hemolytic Disease of Newborn].
Song J; Yang T; Zhou XF; Yang YZ; Peng DL; Zhang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):547-551. PubMed ID: 35395995
[TBL] [Abstract][Full Text] [Related]
17. The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers.
Talwar M; Jain A; Sharma RR; Kumar P; Saha SC; Singh L
Vox Sang; 2022 Sep; 117(9):1112-1120. PubMed ID: 35667836
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of Correlation between IgG Titer of Pregnant Women and Neonatal Hemolytic Complications of Different Blood Groups].
Ye HH; Huang HH; Wang XL; Pi YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1532-1536. PubMed ID: 29070139
[TBL] [Abstract][Full Text] [Related]
19. Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother.
Drabik-Clary K; Reddy VV; Benjamin WH; Boctor FN
Ann Clin Lab Sci; 2006; 36(2):205-7. PubMed ID: 16682519
[TBL] [Abstract][Full Text] [Related]
20. From A to AB: A Caucasian Mother with High Anti-B Titer Causing Hemolytic Disease of the Newborn.
Schooley N; Chabra S; Stolla M
Lab Med; 2022 Mar; 53(2):e33-e35. PubMed ID: 34388252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
